 Christine Swanson
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Density | 12 | 2024 | 486 | 3.740 |
Why?
| | Sleep | 10 | 2022 | 751 | 3.180 |
Why?
| | Sleep Deprivation | 6 | 2022 | 174 | 2.530 |
Why?
| | Bone Remodeling | 5 | 2022 | 74 | 2.180 |
Why?
| | Bone and Bones | 8 | 2023 | 317 | 2.140 |
Why?
| | Circadian Rhythm | 6 | 2021 | 463 | 1.370 |
Why?
| | Bone Resorption | 4 | 2021 | 86 | 0.890 |
Why?
| | Vitamin D | 5 | 2023 | 392 | 0.860 |
Why?
| | Procollagen | 3 | 2020 | 22 | 0.850 |
Why?
| | Femur Neck | 2 | 2020 | 63 | 0.820 |
Why?
| | Bone Diseases | 1 | 2023 | 63 | 0.790 |
Why?
| | Circadian Clocks | 2 | 2019 | 50 | 0.750 |
Why?
| | Collagen Type I | 7 | 2021 | 133 | 0.750 |
Why?
| | Shift Work Schedule | 1 | 2021 | 11 | 0.730 |
Why?
| | Osteogenesis | 2 | 2020 | 187 | 0.710 |
Why?
| | Calcium | 5 | 2021 | 1233 | 0.690 |
Why?
| | Peptide Fragments | 3 | 2020 | 707 | 0.630 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 50 | 0.610 |
Why?
| | Biomarkers | 7 | 2022 | 4148 | 0.600 |
Why?
| | Chronobiology Disorders | 1 | 2017 | 13 | 0.560 |
Why?
| | Osteocalcin | 3 | 2022 | 36 | 0.540 |
Why?
| | Postmenopause | 1 | 2019 | 361 | 0.540 |
Why?
| | Parathyroid Hormone | 5 | 2021 | 108 | 0.530 |
Why?
| | 25-Hydroxyvitamin D 2 | 1 | 2014 | 7 | 0.450 |
Why?
| | Calcifediol | 1 | 2014 | 33 | 0.440 |
Why?
| | Bone Diseases, Metabolic | 1 | 2015 | 62 | 0.440 |
Why?
| | Calcitriol | 1 | 2014 | 58 | 0.430 |
Why?
| | Hip Fractures | 1 | 2015 | 95 | 0.430 |
Why?
| | Hypercalcemia | 1 | 2013 | 19 | 0.430 |
Why?
| | Osteoporotic Fractures | 1 | 2014 | 61 | 0.410 |
Why?
| | Peptides | 6 | 2021 | 981 | 0.400 |
Why?
| | Cat Diseases | 1 | 2012 | 21 | 0.390 |
Why?
| | Exercise | 4 | 2021 | 2015 | 0.390 |
Why?
| | Nicotinic Agonists | 1 | 2013 | 130 | 0.380 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 73 | 0.370 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2012 | 78 | 0.360 |
Why?
| | Hyperglycemia | 2 | 2012 | 344 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 234 | 0.350 |
Why?
| | Nicotine | 1 | 2013 | 338 | 0.350 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 290 | 0.340 |
Why?
| | Life Style | 1 | 2012 | 480 | 0.310 |
Why?
| | Humans | 30 | 2024 | 136899 | 0.310 |
Why?
| | Prediabetic State | 1 | 2012 | 247 | 0.300 |
Why?
| | Male | 21 | 2024 | 67308 | 0.300 |
Why?
| | Bariatric Surgery | 1 | 2011 | 213 | 0.290 |
Why?
| | Obesity, Morbid | 1 | 2011 | 257 | 0.280 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2012 | 345 | 0.280 |
Why?
| | Hospitalists | 1 | 2011 | 243 | 0.270 |
Why?
| | Hypoglycemia | 1 | 2011 | 442 | 0.260 |
Why?
| | Female | 18 | 2024 | 72703 | 0.260 |
Why?
| | Aged | 11 | 2024 | 23641 | 0.240 |
Why?
| | Health Promotion | 1 | 2012 | 744 | 0.240 |
Why?
| | Absorptiometry, Photon | 3 | 2024 | 251 | 0.240 |
Why?
| | Alendronate | 1 | 2024 | 15 | 0.230 |
Why?
| | Blood Chemical Analysis | 2 | 2016 | 98 | 0.230 |
Why?
| | Bone Density Conservation Agents | 1 | 2024 | 80 | 0.210 |
Why?
| | Middle Aged | 12 | 2024 | 33118 | 0.210 |
Why?
| | Caloric Restriction | 1 | 2024 | 119 | 0.200 |
Why?
| | Pathology, Veterinary | 1 | 2022 | 1 | 0.200 |
Why?
| | Sweating | 2 | 2019 | 40 | 0.200 |
Why?
| | Adult | 11 | 2021 | 37595 | 0.190 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 533 | 0.190 |
Why?
| | Resistance Training | 1 | 2024 | 158 | 0.190 |
Why?
| | Dog Diseases | 1 | 2022 | 62 | 0.180 |
Why?
| | Pressoreceptors | 1 | 2021 | 19 | 0.180 |
Why?
| | Baroreflex | 1 | 2021 | 57 | 0.170 |
Why?
| | Weight Loss | 3 | 2024 | 765 | 0.170 |
Why?
| | Aged, 80 and over | 3 | 2019 | 7552 | 0.170 |
Why?
| | Cross-Sectional Studies | 4 | 2021 | 5398 | 0.160 |
Why?
| | Postoperative Complications | 1 | 2011 | 2627 | 0.160 |
Why?
| | Athletes | 1 | 2023 | 403 | 0.160 |
Why?
| | Young Adult | 4 | 2020 | 13157 | 0.160 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2019 | 41 | 0.150 |
Why?
| | Actigraphy | 1 | 2019 | 108 | 0.150 |
Why?
| | Walking | 2 | 2021 | 514 | 0.150 |
Why?
| | Vasoconstriction | 1 | 2019 | 202 | 0.140 |
Why?
| | Brachial Artery | 1 | 2019 | 200 | 0.140 |
Why?
| | Skin | 2 | 2019 | 750 | 0.140 |
Why?
| | Menopause | 1 | 2021 | 315 | 0.140 |
Why?
| | Hip Joint | 1 | 2019 | 170 | 0.140 |
Why?
| | Body Weight | 1 | 2022 | 973 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 2508 | 0.140 |
Why?
| | Body Mass Index | 2 | 2019 | 2351 | 0.140 |
Why?
| | Health | 1 | 2017 | 84 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 429 | 0.140 |
Why?
| | Polysomnography | 1 | 2017 | 184 | 0.130 |
Why?
| | Vitamin D-Binding Protein | 1 | 2016 | 15 | 0.130 |
Why?
| | Hot Temperature | 1 | 2019 | 407 | 0.130 |
Why?
| | Animals | 5 | 2022 | 36915 | 0.120 |
Why?
| | Chromatography, Liquid | 2 | 2016 | 433 | 0.120 |
Why?
| | Vasodilation | 1 | 2019 | 494 | 0.120 |
Why?
| | Pilot Projects | 1 | 2020 | 1684 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2021 | 548 | 0.110 |
Why?
| | Self Report | 1 | 2019 | 827 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2015 | 5126 | 0.110 |
Why?
| | Carbonated Water | 1 | 2013 | 1 | 0.110 |
Why?
| | Chewing Gum | 1 | 2013 | 9 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 849 | 0.110 |
Why?
| | Administration, Cutaneous | 1 | 2013 | 128 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 922 | 0.100 |
Why?
| | Radiography | 1 | 2015 | 834 | 0.100 |
Why?
| | Clinical Laboratory Information Systems | 1 | 2011 | 7 | 0.090 |
Why?
| | Cats | 1 | 2012 | 211 | 0.090 |
Why?
| | Hospital Bed Capacity | 1 | 2011 | 25 | 0.090 |
Why?
| | Patient Dropouts | 1 | 2012 | 67 | 0.090 |
Why?
| | Heart Rate | 3 | 2021 | 830 | 0.090 |
Why?
| | Urban Health | 1 | 2011 | 92 | 0.090 |
Why?
| | Time Factors | 2 | 2019 | 6802 | 0.090 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2012 | 83 | 0.090 |
Why?
| | Hospitals, Community | 1 | 2011 | 50 | 0.090 |
Why?
| | Rural Health | 1 | 2011 | 79 | 0.090 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 116 | 0.090 |
Why?
| | Glucose Intolerance | 1 | 2012 | 146 | 0.090 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 227 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1863 | 0.070 |
Why?
| | Biopsy | 1 | 2012 | 1130 | 0.070 |
Why?
| | Adolescent | 3 | 2023 | 21402 | 0.070 |
Why?
| | Weight Gain | 1 | 2012 | 518 | 0.070 |
Why?
| | Incidence | 1 | 2015 | 2783 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2012 | 657 | 0.070 |
Why?
| | Heart Failure | 1 | 2021 | 2210 | 0.070 |
Why?
| | Overweight | 1 | 2012 | 554 | 0.070 |
Why?
| | Neoplasms | 1 | 2022 | 2655 | 0.070 |
Why?
| | Motor Activity | 1 | 2012 | 722 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5730 | 0.060 |
Why?
| | Intensive Care Units | 1 | 2011 | 795 | 0.060 |
Why?
| | Homeostasis | 2 | 2019 | 622 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2011 | 695 | 0.060 |
Why?
| | Prevalence | 1 | 2011 | 2709 | 0.060 |
Why?
| | United States | 2 | 2012 | 14595 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2744 | 0.050 |
Why?
| | Cohort Studies | 1 | 2014 | 5711 | 0.050 |
Why?
| | Risk Factors | 2 | 2015 | 10313 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2542 | 0.050 |
Why?
| | Child | 1 | 2023 | 21896 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1774 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1033 | 0.050 |
Why?
| | Blood Glucose | 1 | 2011 | 2161 | 0.050 |
Why?
| | Osteoporosis | 1 | 2024 | 241 | 0.050 |
Why?
| | Valsalva Maneuver | 1 | 2021 | 9 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 411 | 0.040 |
Why?
| | Norepinephrine | 1 | 2021 | 212 | 0.040 |
Why?
| | Medical Oncology | 1 | 2022 | 289 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2019 | 29 | 0.040 |
Why?
| | Follicle Stimulating Hormone | 1 | 2021 | 244 | 0.040 |
Why?
| | Sweat | 1 | 2019 | 46 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 678 | 0.040 |
Why?
| | Acidosis | 1 | 2019 | 101 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1460 | 0.040 |
Why?
| | Research Design | 1 | 2024 | 1108 | 0.040 |
Why?
| | Ions | 1 | 2018 | 72 | 0.040 |
Why?
| | Cold Temperature | 1 | 2019 | 177 | 0.040 |
Why?
| | Exercise Test | 1 | 2021 | 621 | 0.040 |
Why?
| | Endothelin-1 | 1 | 2019 | 181 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2011 | 15514 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1114 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 820 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2019 | 1302 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3290 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 2966 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 2060 | 0.020 |
Why?
|
|
Swanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|